References
- Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1. doi:https://doi.org/10.1186/s40733-016-0029-3.
- Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, Casey DC, Charlson FJ, Chen AZ, Coates MM, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–1544. doi:https://doi.org/10.1016/S0140-6736(16)31012-1.
- Global Initiative for Asthma. Global strategy for asthma management and prevention (GINA); 2018. http://www.ginasthma.org. [last accessed 22 July 2019]
- Hekking P-PW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896–902. doi:https://doi.org/10.1016/j.jaci.2014.08.042.
- Bousquet J, Mantzouranis E, Cruz AA, Aït-Khaled N, Baena-Cagnani CE, Bleecker ER, Brightling CE, Burney P, Bush A, Busse WW, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization consultation on severe asthma. J Allergy Clin Immunol. 2010;126(5):926–938. doi:https://doi.org/10.1016/j.jaci.2010.07.019.
- Parulekar AD, Atik MA, Hanania NA. Periostin, a novel biomarker of TH2-driven asthma. Curr Opin Pulm Med. 2014;20(1):60–65. doi:https://doi.org/10.1097/MCP.0000000000000005.
- I zuhara K, Conway SJ, Moore BB, Matsumoto H, Holweg CTJ, Matthews JG, Arron JR. Roles of periostin in respiratory disorders. Am J Respir Crit Care Med. 2016;193(9):949. doi:https://doi.org/10.1164/rccm.201510-2032PP.
- Izuhara K, Arima K, Ohta S, Suzuki S, Inamitsu M, Yamamoto K. Periostin in allergic inflammation. Allergol Int. 2014;63(2):143–151. doi:https://doi.org/10.2332/allergolint.13-RAI-0663.
- Matsumoto H. Serum periostin: a novel biomarker for asthma management. Allergol Int. 2014;63(2):153doi:https://doi.org/10.2332/allergolint.13-RAI-0678.
- Izuhara K, Matsumoto H, Ohta S, Ono J, Arima K, Ogawa M. Recent developments regarding periostin in bronchial asthma. Allergol Int. 2015;64:S3e10. doi:https://doi.org/10.1016/j.alit.2015.04.012.
- Li W, Gao P, Zhi Y, Xu W, Wu Y, Yin J, Zhang J. Periostin: its role in asthma and its potential as a diagnostic or therapeutic target. Respir Res. 2015;16:57. doi:https://doi.org/10.1186/s12931-015-0218-2.
- Anderson HM, Lemanske RF, Arron JR, Holweg CTJ, Rajamanickam V, Gangnon RE, Gern JE, Jackson DJ. Relationships among aeroallergen sensitization, peripheral blood eosinophils, and periostin in pediatric asthma development. J Allergy Clin Immunol. 2017;139(3):790–796. doi:https://doi.org/10.1016/j.jaci.2016.05.033.
- James A, Janson C, Malinovschi A, Holweg C, Alving K, Ono J, Ohta S, Ek A, Middelveld R, Dahlén B, et al. Serum periostin relates to type-2 inflammation and lung function in asthma: data from the large population-based cohort Swedish GA(2)LEN. Allergy 2017;72(11):1753–1760. doi:https://doi.org/10.1111/all.13181.
- Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–373. doi:https://doi.org/10.1183/09031936.00202013.
- Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:https://doi.org/10.1183/09031936.05.00034805.
- Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MSM, Zheng J, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations . Eur Respir J. 2012;40(6):1324–1343. doi:https://doi.org/10.1183/09031936.00080312.
- Koshak EA. Skin test reactivity to indoor allergens correlates with asthma severity in Jeddah, Saudi Arabia. Allergy Asthma Clin Immunol. 2006;2(1):11–19. doi:https://doi.org/10.1186/1710-1492-2-1-11.
- Gammeri E, Arena A, D’Anneo R, La Grutta S. Safety and tolerability of ultra-rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma. Allergol Immunopathol (Madr). 2005;33(3):142–144. doi:https://doi.org/10.1157/13075710.
- Simpson JL, McElduff P, Gibson PG. Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration 2010;79(2):147–151. doi:https://doi.org/10.1159/000245899.
- Simpson JL, Phipps S, Baines KJ, Oreo KM, Gunawardhana L, Gibson PG. Elevated expression of the NLRP3 inflammasome in neutrophilic asthma. Eur Respir J. 2014;43(4):1067–1076. doi:https://doi.org/10.1183/09031936.00105013.
- Bobolea I, Barranco P, Del Pozo V, Romero D, Sanz V, López-Carrasco V, Canabal J, Villasante C, Quirce S. Sputum periostin in patients with different severe asthma phenotypes. Allergy 2015;70(5):540–546. doi:https://doi.org/10.1111/all.12580.
- Cianchetti S, Brighindi S, Bacci E, Cardini C, Dente FL, Latorre M, Puxeddu I, Paggiaro P. Distinct profile of inflammatory and remodeling biomarkers in sputum of severe asthmatic patients with or without persistent airway obstruction. Am J Respir Crit Care Med. 2018;197:A24–A87.
- Carpagnano GE, Scioscia G, Lacedonia D, Soccio P, Lepore G, Saetta M, Foschino Barbaro MP, Barnes PJ. Looking for airways periostin in severe asthma: could it be useful for clustering type 2 endotype? Chest. 2018;154(5):1083–1090. doi:https://doi.org/10.1016/j.chest.2018.08.1032.
- Wardzyńska A, Makowska JS, Pawełczyk M, Piechota-Polańczyk A, Kurowski M, Kowalski ML. Periostin in exhaled breath condensate and in serum of asthmatic patients: relationship to upper and lower airway disease. Allergy Asthma Immunol Res 2017;9(2):126–132. doi:https://doi.org/10.4168/aair.2017.9.2.126.
- Kanemitsu Y, Matsumoto H, Izuhara K, Tohda Y, Kita H, Horiguchi T, Kuwabara K, Tomii K, Otsuka K, Fujimura M, et al. Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids. J Allergy Clin Immunol. 2013;132(2):305–312.e3. doi:https://doi.org/10.1016/j.jaci.2013.04.050.
- Fingleton J, Braithwaite I, Travers J, Bowles D, Strik R, Siebers R, Holweg C, Matthews J, Weatherall M, Beasley R, et al. Serum periostin in obstructive airways disease. Eur Respir J. 2016;47(5):1383–1391. doi:https://doi.org/10.1183/13993003.01384-2015.
- Song J-S, You J-S, Jeong S-I, Yang S, Hwang I-T, Im Y-G, Baek H-S, Kim H-Y, Suh D-I, Lee H-B, et al. Serum periostin levels correlate with airway hyper-responsiveness to methacholine and mannitol in children with asthma. Allergy 2015;70(6):674–681. doi:https://doi.org/10.1111/all.12599.
- Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010;65(5):384–390. doi:https://doi.org/10.1136/thx.2009.126722.
- Simpson JL, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Jia G, Holweg CTJ. Periostin levels and eosinophilic inflammation in poorly-controlled asthma. BMC Pulm Med. 2016;16(1):1–4. doi:https://doi.org/10.1186/s12890-016-0230-4.
- Górska K, Maskey-Warzęchowska M, Nejman-Gryz P, Korczyński P, Prochorec-Sobieszek M, Krenke R. Comparative study of periostin expression in different respiratory samples in patients with asthma and chronic obstructive pulmonary disease. Pol Arch Med Wewn. 2016;126(3):124–137. doi:https://doi.org/10.20452/pamw.3299.